Pharmaceutical Technology Europe
Testing the dissolution rates of a pharmaceutical formulation (also known as in vitro availability) aids drug quality control and is a compulsory requirement of the British, European and US pharmacopoeias.
Ana Rita Pires
Advertisement
Ana Rita Pires is a PhD student at the University of Porto (Portugal).
Articles by Ana Rita Pires
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
A Lifecycle Approach to Peptide Formulation in Prefilled Syringes for High-Speed Autoinjector Assembly
3
How to Support Emerging Biopharma Programs Through Rapid Candidate Identification
4